27,226 Shares in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Acquired by Beck Bode LLC

Beck Bode LLC purchased a new position in shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 27,226 shares of the biopharmaceutical company’s stock, valued at approximately $42,000. Several other hedge funds have also added to or reduced their stakes in INO. MetLife Investment Management LLC […]

Related Keywords

Canada , ,Vanguard Group Inc ,Hsbc Holdings ,Beck Bode ,Nasdaq ,News Ratings For Inovio Pharmaceuticals Daily ,Quarter For Inovio Pharmaceuticals ,Inovio Pharmaceuticals ,Charles Schwab Investment Management Inc ,Inovio Pharmaceuticals Inc ,Royal Bank ,Renaissance Technologies ,Metlife Investment Management ,Inovio Pharmaceuticals Trading ,Get Rating ,Life Investment Management ,Schwab Investment Management ,Visit Holdingschannel ,Inovio Pharmaceuticals Daily ,Nasdaq Ino ,Ino ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,